Body Diffusion-weighted MR Imaging in Oncology: Imaging at 3 T.
暂无分享,去创建一个
Matthew Blackledge | Dow-Mu Koh | David J Collins | Leonardo Kayat Bittencourt | D. Collins | D. Koh | M. Blackledge | L. Bittencourt | Jeong-min Lee | Jeong-Min Lee
[1] D. Yeung,et al. Non-Gaussian Analysis of Diffusion Weighted Imaging in Head and Neck at 3T: A Pilot Study in Patients with Nasopharyngeal Carcinoma , 2014, PloS one.
[2] A. Wetter,et al. Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [18F] Choline PET/MRI , 2014, PloS one.
[3] M. Forsting,et al. Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system? , 2013, European journal of radiology.
[4] Bong Joo Kang,et al. Readout-segmented echo-planar imaging in diffusion-weighted mr imaging in breast cancer: comparison with single-shot echo-planar imaging in image quality. , 2014 .
[5] Dwight G. Nishimura,et al. Clinical Evaluation of Reduced Field-of-View Diffusion-Weighted Imaging of the Cervical and Thoracic Spine and Spinal Cord , 2012, American Journal of Neuroradiology.
[6] Y. Ohgiya,et al. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. , 2014, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[7] M. Forsting,et al. Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection? , 2013, European journal of radiology.
[8] Y. Jeong,et al. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: Diffusion‐weighted 3 tesla MR imaging , 2012, Journal of magnetic resonance imaging : JMRI.
[9] G. Adam,et al. MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (1H) MR Spectroscopy in Comparison with Histology , 2010, Radiology research and practice.
[10] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[11] D. Porter,et al. Readout-segmented echo-planar imaging for diffusion-weighted imaging in the pelvis at 3T-A feasibility study. , 2014, Academic radiology.
[12] Magalie Viallon,et al. Improvement of renal diffusion-weighted magnetic resonance imaging with readout-segmented echo-planar imaging at 3T. , 2015, Magnetic resonance imaging.
[13] T. Metens,et al. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.
[14] C. Kim,et al. Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion‐weighted MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[15] D. Collins,et al. Assessing response in bone metastases in prostate cancer with diffusion weighted MRI , 2011, European Radiology.
[16] P. Boesiger,et al. High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV technique. , 2011, European journal of radiology.
[17] M. Okada,et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.
[18] Emmanuel Itti,et al. Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma: Pilot Study , 2011, Investigative radiology.
[19] H. Eskola,et al. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B‐cell lymphoma – a whole‐body MRI and diffusion‐weighted imaging study , 2013, NMR in biomedicine.
[20] A. Stecco,et al. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases , 2013, La radiologia medica.
[21] S. Skare,et al. Readout-segmented EPI for rapid high resolution diffusion imaging at 3 T. , 2008, European journal of radiology.
[22] D. Collins,et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. , 2012, AJR. American journal of roentgenology.
[23] D. Alain,et al. Whole-body diffusion-weighted MRI for staging lymphoma at 3.0T: comparative study with MR imaging at 1.5T. , 2015, Clinical imaging.
[24] B. Seifert,et al. Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. , 2014, Radiology.
[25] M. Fenchel,et al. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results. , 2011, AJR. American journal of roentgenology.
[26] Dwight G Nishimura,et al. Hadamard slice encoding for reduced‐FOV diffusion‐weighted imaging , 2014, Magnetic resonance in medicine.
[27] S. Dymarkowski,et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT , 2014, European Radiology.
[28] H. Chandarana,et al. PET/MRI for the evaluation of patients with lymphoma: initial observations. , 2015, AJR. American journal of roentgenology.
[29] G. Johnson,et al. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. , 2012, Radiology.
[30] High-Resolution Diffusion-Weighted Imaging of Neck Lymph Nodes Using 2D-Single-Shot Interleaved Multiple Inner Volume Imaging Diffusion-Weighted Echo-Planar Imaging at 3T , 2011, American Journal of Neuroradiology.
[31] A. Ba-Ssalamah,et al. Confident non-invasive diagnosis of pseudolesions of the liver using diffusion-weighted imaging at 3T MRI. , 2012, European journal of radiology.
[32] Robin M Heidemann,et al. High resolution diffusion‐weighted imaging using readout‐segmented echo‐planar imaging, parallel imaging and a two‐dimensional navigator‐based reacquisition , 2009, Magnetic resonance in medicine.
[33] L. Fayad,et al. Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis , 2013, ISRN radiology.
[34] A. Chhabra,et al. Anatomic MR Imaging and Functional Diffusion Tensor Imaging of Peripheral Nerve Tumors and Tumorlike Conditions , 2013, American Journal of Neuroradiology.
[35] Hee Jung Shin,et al. Comparison of readout segmented echo planar imaging (EPI) and EPI with reduced field‐of‐VIew diffusion‐weighted imaging at 3t in patients with breast cancer , 2015, Journal of magnetic resonance imaging : JMRI.
[36] S. Skare,et al. Robust GRAPPA‐accelerated diffusion‐weighted readout‐segmented (RS)‐EPI , 2009, Magnetic resonance in medicine.
[37] B. K. Park,et al. Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy , 2008, Investigative Radiology.
[38] A. Wetter,et al. Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis , 2014, Annals of Nuclear Medicine.
[39] H. Merisaari,et al. Evaluation of different mathematical models for diffusion‐weighted imaging of normal prostate and prostate cancer using high b‐values: A repeatability study , 2015, Magnetic resonance in medicine.
[40] T. Tsuchida,et al. Evaluation of staging and early response to chemotherapy with whole‐body diffusion‐weighted MRI in malignant lymphoma patients: A comparison with FDG‐PET/CT , 2015, Journal of magnetic resonance imaging : JMRI.
[41] Byung Kwan Park,et al. Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.
[42] Robert Turner,et al. Diffusion imaging in humans at 7T using readout‐segmented EPI and GRAPPA , 2010, Magnetic resonance in medicine.
[43] Takeshi Yoshikawa,et al. Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.
[44] C. Geppert,et al. Zoomed echo-planar imaging using parallel transmission: impact on image quality of diffusion-weighted imaging of the prostate at 3T , 2014, Abdominal Imaging.
[45] Zhaoqin Huang,et al. Diffusion-weighted imaging of prostate cancer on 3T MR: Relationship between apparent diffusion coefficient values and Ki-67 expression. , 2013, Academic radiology.
[46] Timothy D Johnson,et al. Multi‐system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice‐water phantom , 2013, Journal of magnetic resonance imaging : JMRI.
[47] G. Morgan,et al. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. , 2014, Radiology.
[48] P. Heusch,et al. Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI , 2015, PloS one.
[49] T. Helbich,et al. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. , 2015, Radiology.
[50] Wolfgang Bogner,et al. Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T. , 2012, Radiology.
[51] Laurence Collette,et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? , 2012, European urology.
[52] A. Cotten,et al. Assessment of reduced field of view in diffusion tensor imaging of the lumbar nerve roots at 3 T , 2013, European Radiology.
[53] J. Deasy,et al. Repeatability Investigation of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging on Thyroid Glands , 2015, Journal of computer assisted tomography.
[54] V. Taviani,et al. 3T diffusion-weighted MRI of the thyroid gland with reduced distortion: preliminary results. , 2013, The British journal of radiology.
[55] Yu-Dong Zhang,et al. Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer. , 2015, Urologic oncology.
[56] C. Geppert,et al. Diffusion-weighted imaging of the liver: comparison of image quality between monopolar and bipolar acquisition schemes at 3T , 2015, Abdominal Imaging.
[57] M. Rengo,et al. Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging , 2012, Abdominal Imaging.
[58] S. Schoenberg,et al. Feasibility study of computed vs measured high b-value (1400 s/mm²) diffusion-weighted MR images of the prostate. , 2014, World journal of radiology.
[59] Josef Pfeuffer,et al. Diffusion-weighted MRI of the Prostate: Advantages of Zoomed EPI with Parallel-transmit-accelerated 2D-selective Excitation Imaging , 2014, European Radiology.
[60] Takeo Ishigaki,et al. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.
[61] L. Fayad,et al. Differentiation of benign and malignant skeletal lesions with quantitative diffusion weighted MRI at 3T. , 2015, European journal of radiology.
[62] Peter Boesiger,et al. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations. , 2010, Radiology.
[63] Baris Turkbey,et al. Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer , 2015, Abdominal Imaging.
[64] P. Boesiger,et al. Reduced field‐of‐view MRI using outer volume suppression for spinal cord diffusion imaging , 2007, Magnetic resonance in medicine.
[65] G. Zaharchuk,et al. Reduced Field-of-View Diffusion Imaging of the Human Spinal Cord: Comparison with Conventional Single-Shot Echo-Planar Imaging , 2011, American Journal of Neuroradiology.
[66] T. Yen,et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion‐weighted magnetic resonance imaging at 3T , 2008, Journal of magnetic resonance imaging : JMRI.
[67] D. Porter,et al. Readout-Segmented Echo-Planar Imaging in Diffusion-Weighted MR Imaging in Breast Cancer: Comparison with Single-Shot Echo-Planar Imaging in Image Quality , 2014, Korean journal of radiology.
[68] H. Rusinek,et al. Whole‐lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy , 2015, Journal of magnetic resonance imaging : JMRI.
[69] D. Collins,et al. Assessment of Treatment Response by Total Tumor Volume and Global Apparent Diffusion Coefficient Using Diffusion-Weighted MRI in Patients with Metastatic Bone Disease: A Feasibility Study , 2014, PloS one.
[70] B. K. Park,et al. Diffusion-Weighted Imaging of the Prostate at 3 T for Differentiation of Malignant and Benign Tissue in Transition and Peripheral Zones: Preliminary Results , 2007, Journal of computer assisted tomography.
[71] C. Geppert,et al. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. , 2013, AJR. American journal of roentgenology.
[72] Dow-Mu Koh,et al. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[73] A. Padhani,et al. Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[74] A. Padhani,et al. Diffusion MR imaging for monitoring of treatment response. , 2011, Magnetic resonance imaging clinics of North America.
[75] Y. Ohgiya,et al. Utility of apparent diffusion coefficients in the evaluation of solid renal tumors at 3T. , 2014, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[76] D. Collins,et al. Therapy monitoring of skeletal metastases with whole‐body diffusion MRI , 2014, Journal of magnetic resonance imaging : JMRI.
[77] Valentina Taviani,et al. Assessment of tumor morphology on diffusion‐weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI , 2015, Journal of magnetic resonance imaging : JMRI.
[78] Ke Sheng,et al. Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer , 2011, Advances in urology.
[79] C. Lehman,et al. Improved B1 homogeneity of 3 tesla breast MRI using dual‐source parallel radiofrequency excitation , 2012, Journal of magnetic resonance imaging : JMRI.
[80] Dwight G Nishimura,et al. High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. , 2012, Academic radiology.
[81] John Kurhanewicz,et al. Reduced-FOV excitation decreases susceptibility artifact in diffusion-weighted MRI with endorectal coil for prostate cancer detection. , 2015, Magnetic resonance imaging.
[82] C. Kim,et al. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. , 2010, AJR. American journal of roentgenology.
[83] D. Choi,et al. Endometrial cancer: Utility of diffusion‐weighted magnetic resonance imaging with background body signal suppression at 3T , 2013, Journal of magnetic resonance imaging : JMRI.
[84] G. Martinelli,et al. Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin’s lymphoma for staging and treatment response , 2014, Ecancermedicalscience.